The Business Times
SUBSCRIBERS

Corporate digest

google-preferred-sourceAdd BT as a preferred source
Published Mon, Apr 13, 2020 · 09:50 PM

Biolidics

THE cancer diagnostics company said it has notified and received acknowledgement from the US Food and Drug Administration for the intended distribution of its Covid-19 rapid test kits in the US.

The Catalist-listed firm's kits will be allowed for use by clinical laboratories or healthcare workers for point-of-care testing, but not for home testing.

Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

Corporate Digest

Copyright SPH Media. All rights reserved.

Reuse this contentFeedback
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More